论文部分内容阅读
我院1991～1995年间共收治原发性肝癌(以下称肝癌)患者480例,其中晚期肝癌456例,占95％,早期肝癌仅24例,占5％。其中手术切除者320例,占66.7％(包括姑息切除122例,占38.1％),可见相当部分肝癌患者就诊时已失去手术切除机会。为延长这部分患者的生存时间,且提高晚期肝癌患者的生活质量,对未能行手术切除的120例患者采用选择性肝动脉栓塞化疗加门静脉置泵化疗,取得了较好的效果。所谓选择性肝动脉栓塞就是只栓塞供应肿瘤局部的肝动脉,而不是栓塞肝固有动脉。现报告如下。
In our hospital from 1991 to 1995 a total of 480 cases of primary liver cancer (hereinafter referred to as liver cancer) patients were treated, including 456 cases of advanced liver cancer, accounting for 95%, only 24 cases of early liver cancer, accounting for 5%. Among them, 320 were surgical resections, accounting for 66.7% (including 122 cases of palliative resection, accounting for 38.1%). It can be seen that a considerable part of liver cancer patients have lost the chance of surgical resection. In order to prolong the survival time of these patients and improve the quality of life of patients with advanced liver cancer, 120 patients who failed to undergo surgical resection were treated with selective hepatic artery embolization chemotherapy and portal vein pump chemotherapy, and achieved good results. The so-called selective hepatic artery embolization is to embolize only the local hepatic artery, rather than to embolize the proper hepatic artery. The report is as follows.